注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Norio Aikawa | 74 | 2004 | Head of Drug Discovery & Support Business, Head of IP & Legal Department and Director |
Kohichiro Yoshino | 73 | 2003 | CEO, President & Representative Director |
Tsuguo Ogasawara | 84 | 2005 | Independent Outside Director |
Teruo Takayanagi | 77 | 2015 | Independent Outside Director |
Atsuo Arita | 80 | 2004 | Independent Outside Director |
Takao Matsui | - | 2019 | Independent Outside Director |
Emi Yamamoto | 53 | 2015 | GM of Business Mgt., Accounting, HR, General Affairs, CFO, Director & President - CarnaBio USA |
Masaaki Sawa | 53 | 2015 | GM of Research & Development Division, Chief Scientific Officer and Director |
Akinori Arimura | 60 | 2019 | GM of Clinical Development, R&D, Chief Development Officer of CarnaBio USA & Director |
Kaoru Suzuki | - | 2024 | Independent Outside Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核